In a study initially designed to evaluate reinnervation of human cutaneous wounds using an antibody to the neuroneal marker protein gene product (PGP) 9.5, we observed marked immunostaining of cells with morphologic features of fibroblasts in the wounds. PGP 9.5 has recently been shown to be an important enzyme in the highly conserved ubiquitin system of proteolysis. Because the ubiquitin system is known to play an important role in regulating the cell cycle, the presence of PGP 9.5 in cells at a wound site was of considerable interest. Our objectives were to clarify the time frame for the appearance of PGP 9.5 and ubiquitin in wounds, to verify that PGP 9.5 is produced by wound fibroblasts, and to evaluate a potential role for these proteins in the tissue repair process. Standard incisional human wounds were stained with antibodies specific for PGP 9.5 and ubiquitin. At 7 d, stellate cells with morphologic features of fibroblasts stained for PGP 9.5, whereas earlier wounds were generally negative. In 14 and 21 d incised wounds and in P rotein gene product 9.5 (PGP 9.5) is widely used as a marker for cutaneous innervation. The 26 kDa protein was isolated from brain tissue (Jackson and Thompson, 1981) and subsequently shown to be an enzyme of the ubiquitin system (ubiquitin C-terminal hydrolase) (Wilkinson et al, 1989) .
chronic granulation tissue from nonhealing ulcers there was strong cellular staining for PGP 9.5 and for ubiquitin. These stellate cells also showed expression of mRNA for PGP 9.5 by reverse transcriptase-polymerase chain reaction in situ hybridization. PGP 9.5 was detected in cultured fibroblasts both by reverse transcriptasepolymerase chain reaction and by northern blot analysis. Confocal microscopy showed colocalization of antibodies to PGP 9.5 and prolyl-4-hydroxylase (a fibroblast marker) as well as colocalization of PGP 9.5 and the platelet derived growth factor β receptor. We conclude that ubiquitin and PGP 9.5 were expressed by fibroblasts during the granulation tissue and remodeling phases wound healing. The mRNA for PGP 9.5 was demonstrated in stellate cells in chronic wounds and in fibroblasts in culture. The appearance of these degradative proteins in later wounds suggests a downregulation function in the wound healing response. Key words: nerves/PGP 9.5/ ubiquitin/wound healing. J Invest Dermatol 111:565-572, 1998 et al, 1992) . PDGF is known to stimulate both mitogenesis and fibrogenesis in fibroblasts (Ross et al, 1986) , which are key functions in the wound healing process. Other cytokine receptor/ligand complexes known to be important in wound healing undergo similar ubiquitin mediated degradations (Mori et al, 1995) . These include platelet derived growth factor alpha-receptor, epidermal growth factor receptor, and fibroblast growth factor-receptor.
In this study we observed marked immunostaining of PGP 9.5 in cells with morphologic features of fibroblasts, particularly in mature wounds (14 and 21 d) . This was an unexpected finding because PGP 9.5 expression was originally thought to be quite specific for neuroneal and neuroendocrine tissue (Thompson et al, 1983) . PGP 9.5 has, however, been detected using two-dimensional gel electrophoresis or immunocytochemistry in non-neuroneal cells from renal distal convoluted tubules, ovarian follicles, corpus luteum, and epididymal epithelium, as well as in spermatogonia and Leydig cells (Wilson et al, 1988; Santamaria et al, 1993) . Prior to our observations in human fibroblasts, 1 the only evidence that fibroblasts produce PGP 9.5 came from two-dimensional immunoblotting, comigration, and microsequencing of proteins recovered from human embryonal MRC-5 lung fibroblasts (Honoré et al, 1991) . More recently, DiPaolo et al (1995) used similar two-dimensional immunoblotting techniques to show the presence of PGP 9.5 in cultured human neonatal foreskin fibroblasts.
We used immunocytochemistry (ICC) to document the presence of both PGP 9.5 and ubiquitin in standard incisional wounds and in chronic decubitus ulcers. Additionally, we wanted to determine if the stellate cells were fibroblasts and whether they produced mRNA for PGP 9.5 as well as expressing the protein. We questioned whether the stellate cells showed coexpression of PGP 9.5 and platelet derived growth factor β receptor (PDGFβ-r), because that would be consistent with a potential mechanism of action in the wound healing process involving degradation of one of the monomeric tyrosine kinase receptors known to be important in wound healing. We used confocal microscopy, transmission electron microscopy (TEM), northern blot analysis, and reverse transcriptase-polymerase chain reaction (RT-PCR) techniques for these studies.
MATERIALS AND METHODS
Standard human wounds and ulcers were studied Simplate-II (General Diagnostics, Organon Teknika, NC) bleeding time devices were used to create wounds on the arms and legs of normal male volunteers 66 Ϯ 6 y of age (mean Ϯ SD). The Simplate-II is a spring loaded instrument that, when activated, projects a pair of blades 5 mm in length, 1 mm in depth, and 3 mm apart. This human wound model has been previously described in detail (Olerud et al, 1995) . Volunteers were recruited using methods approved by the University of Washington Institutional Review Board for Human Subjects (UWIRBHS). All subjects were screened and shown to be free of neuropathy and diabetes mellitus as previously described (Olerud et al, 1995) .
Two 4 mm punch biopsies were removed from wounds 1, 2, 3, 4, 7, 14, and 21 d following injury. Half of each sample was fixed in half strength Karnovsky's fixative 2 and then embedded in Epon 812 (Luft, 1961) for high quality light microscopy and TEM. The other half was either fixed in 4% paraformaldehyde/phosphate buffered saline (PBS) for 24 h and processed for paraffin embedding or frozen in OCT (Tissue Tek, Miles, IN) .
Chronic ulcers were studied. Six paraplegic subjects undergoing surgery to excise and repair chronic sacral decubitus ulcers agreed to allow the study of tissue removed during surgery. Consent was obtained using methods approved by the UWIRBHS. Ulcer tissue was taken immediately upon excision, fixed in 10% neutral buffered formalin, and processed for paraffin embedding or frozen in OCT (Tissue Tek).
Immunostaining techniques (ICC) of wounds
To detect PGP 9.5 and ubiquitin in standard wounds and ulcers Six micron tissue sections of the paraformaldehyde fixed wounds and the neutral buffered formalin fixed ulcers, mounted on Superfrost Plus (Labcraft) glass slides, were deparaffinized and processed for immunoperoxidase with the following solutions: Tris buffered saline (TBS) washes, H 2 O 2 /TBS blocking (1%, 30 min), goat serum/TBS blocking (1.3%, 30 min), polyclonal rabbit PGP 9.5 anti-serum (Accurate Chemical Scientific, Westbury, NJ) at 1:1500 dilution for 1 h at room temperature or polyclonal rabbit ubiquitin anti-serum (Dako, Carpenteria, CA) at 1:250 dilution for 1 h. Diluent used for all antibodies was 0.1% bovine serum albumin in TBS and all incubations were done at room temperature. The secondary antibody was biotinylated goat anti-rabbit antibody (Vector Laboratories, Burlingame, CA) at 1:200 dilution for 30 min, followed by avidinbiotin complex (ABC Universal Kit, Zymed Laboratories, San Francisco, CA) at 1:200 dilution for 30 min. Sections were then visualized for immunoreactivity using 3,3Ј diaminobenzidine (Sigma, St. Louis, MO) as a chromogen (0.12% in H 2 O, 20 min).
To detect PDGFβ-r in standard wounds Frozen sections of wounds washed in TBS were post-fixed with 0.1% glutaraldehyde/TBS for 5 min. The slides were processed as described above except that they were blocked with horse and goat sera/TBS (3% and 1.3%, respectively, 30 min) and incubated with a monoclonal mouse ascites PDGFβ-r antibody (Zymogenetics, Seattle, WA) at 1:1000 dilution for 1 h and secondary biotinylated horse anti-mouse (Vector Laboratories) at 1:200 dilution for 30 min.
To identify wound fibroblasts using antibodies to prolyl-4-hydrolase (5B5) Frozen sections of wounds were post-fixed in cold acetone for 5 min, washed in TBS, and processed as above using a mouse monoclonal anti-human prolyl-4-hydroxylase antibody (5B5) (Dako) at 1:100 dilution and biotinylated horse anti-mouse IgG secondary antibody.
Fluorescence double-labeling
To demonstrate that PGP 9.5 and 5B5 are coexpressed by wound fibroblasts Frozen sections were acetone fixed, washed in TBS, blocked with 1.3% goat and 0.3% horse sera for 30 min, then incubated with PGP 9.5 antibody at 1:1000 dilution and 5B5 antibody at 1:100 dilution for 1 h at room temperature. The diluent for all antibodies contained 0.1% bovine serum albumin and 0.1% Tween 20 (polyoxyethlyenesorbitan monosaurate, Sigma). Sections were then sequencially immunolabeled with a fluorescein-labeled goat anti-rabbit (Vector Laboratories) at 1:200 dilution and biotinylated horse anti-mouse IgG (Vector Laboratories) at 1:400 dilution for 30 min. Slides were rinsed in TBS and immunolabeled with Texas Red Streptavidin (Vector Laboratories) at 1:1600 dilution for 30 min, washed in TBS, then coverslipped using Vectashield (Vector Laboratories) as a mounting medium.
To demonstrate that PGP 9.5 and PDGFβ-r are coexpressed by the same cells Immunolabeling was as above except PDGFβ-r antibody was used (1:500) in place of 5B5.
Laser scanning confocal microscopy
To visualize fluorescent double labeling Image acquisition for the fluorescence double-labeling was on a BioRad MRC-600 confocal microscope equipped with a krypton/argon mixed gas laser. The dual excitation mode was used, passing 488 nm wavelength for fluoroscein isothiocyanate excitation and 568 nm wavelength for Texas Red excitation. Dual image files were first split and then imported into Adobe Photoshop for display purposes, with green for fluoroscein isothiocyanate and red for Texas Red, and then superimposed to show colocalization of label. Color prints were output to a Tektronix dye sublimation printer at 300 dpi.
TEM
To evaluate ultrastructural features of stellate cells Standard 21 d wound specimens that had been fixed directly in half strength Karnovsky's fixative and processed by standard methods for TEM were studied using a Phillips 420 transmission electron microscope.
Detection of PGP-9.5 mRNA in cultured fibroblasts by RT-PCR Oligonucleotide primers were synthesized (Bio-synthesis, Lewisville, TX) corresponding to bp 170-190 5Ј primer, sense CAG CAT GAG AAC TTC AGG AAA, and the complementary reverse sequence against bp 488-508 3Ј primer, anti-sense GCC ATC CAC GTT GTT AAA CAG of PGP 9.5 cDNA as previously described (Day and Thompson, 1987) . RNA was isolated from cultured fibroblasts and reverse transcribed to make complementary cDNA to PGP9.5.
PCR was performed on 0, 1, 2, and 5 µl of the preconfluent and confluent RT reaction products by adding equal amounts of the 3Ј and 5Ј primers, 1.25 ϫ d4NTP mixture (Pharmacia LKB Biotechnology, Piscataway, NJ) and 10 ϫ PCR buffer ϩ MgCl 2 (Boehringer, Indianapolis, IN). Taq polymerase (Boehringer) was added during the hot start at 85°C. Sterile mineral oil also was added to prevent evaporation. The PCR reaction was carried out in a PTC-100-CR machine (MJ Research, Watertown, MA) for 35 cycles using an annealing temperature of 60°C, denaturing temperature of 94°C, and extension temperature of 72°C.
PCR reaction products were digested with restriction enzymes MboI (New England Biolabs, Beverley, MA) and EcoRI (Boehringer, Indianapolis, IN) at 37°C for 2 h. Gel electrophoresis was performed on uncut PCR product, MboI-cut PCR product, and EcoRI-cut PCR product to verify expected size. The uncut RT-PCR product was then sequenced in both directions using a PCR sequencing reaction containing the 5Ј and 3Ј NEP oligonucleotide primer and Dye Terminator with AmpliTaq DNA Polymerase FS (ABI Prism) followed by sequencing using a model 377 Fluorescence Sequencer (ABI Prism).
Detection of PGP 9.5 mRNA in fibroblasts by northern blot analysis Fifteen micrograms of newborn foreskin fibroblast RNA was run on a formaldehyde gel and transferred to Hybond-N nylon membrane (Amersham, Arlington Heights, IL) using a Vacugene apparatus (Pharmacia LKB Biotechnology). The blot was cross-linked and the 28S and 18S bands were marked. Twenty-five nanograms of gel-purified PGP 9.5 cDNA was labeled with 32P-αCTP (Amersham) using the Rediprime DNA labeling system (Amersham). The blot was prehybridized at 65°C for 1 h with Rapid-Hyb buffer (Amersham), then hybridized with the radiolabeled probe at 65°C for 2 h, washed at room temperature with 2 ϫ standard saline citrate containing 0.1% sodium dodecyl sulfate, washed at 65°C with 0.1 ϫ standard saline citrate containing 0.1% sodium dodecyl sulfate, and exposed to film for 16 h at room temperature prior to development.
Detection of PGP 9.5 mRNA in tissue sections by RT-PCR in situ hybridization RT-PCR in situ hybridization was performed to identify cells containing PGP 9.5 mRNA. Six micron, formalin-fixed, paraffin-embedded sections of chronic decubitus ulcers were deparaffinized and rehydrated in 0.5ϫstandard saline citrate followed by rinsing in RNase buffer (500 mM NaCl, 10 mM Tris-HCl, pH 8). Sections were then digested with proteinase K (Sigma) in RNase buffer (20 µg per ml) at 37°C for 10 min, rinsed in 0.5ϫstandard saline citrate and incubated with RQ1 RNase-free DNase (10 µl per ml, Promega, Madison, WI) for 10 min at room temperature, and rinsed in DEPC H 2 O. Slides were covered with RT reaction mixture containing the same ingredients as described above for fibroblast RNA RT reaction. Slides were then incubated at 42°C for 1 h in a humidified chamber, and followed by heat inactivation of the MMLV RT at 65°C for 5 min buffer. Slides were rinsed in sterile dH 2 O and placed in the PCR machine. A PCR reaction mixture consisting of ingredients identical to those described above for the fibroblast PCR reaction, with the exception of replacing d4NTP with biotin 16-dUTP (Boehringer) and 10 mM d3NTPs containing dATP, dGTP, and dCTP, was added to each of the slides during the 85°C hot start and coverslipped with rubber-sealed coverslips (Research Products International, Mount Prospect, IL). Slides were run for 10 cycles at temperatures described above, washed in dH 2 O, and rinsed in PBS. Sections were covered with avidin conjugated to alkaline phosphatase (Dako) in 1% bovine serum albumin/PBS (1:250 dilution) at 37°C for 1 h then washed in Triton/TBS, followed by equilibration in TBS pH 9.5. Colorimetric development was performed using NBT/BCIP (Boehringer) in TBS pH 9.5 for 10 min at room temperature. Reaction was stopped by rinsing in dH 2 O and slides were counterstained with methyl green. Two sets of controls were run in an identical fashion except that one set was run without addition of primers and the other was run without addition of MMLV RT and Taq Polymerase.
PGP 9.5 immunofluorescence and terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) assay
To assess a role for the PGP 9.5/ubiquitin system in wound apoptosis Six micron sections of paraformaldehyde-fixed, paraffin embedded tissue were processed for TUNEL assay according to methods outlined in the ApopTag Plus Kit (Oncor, Gaithersburg, MD) with the following modifications: Histoclear II (National Diagnostics, Atlanta, GA) was used in place of xylene in the deparaffinizing process, Proteinase K (Sigma) was used at 20 µg PBS per ml, 20 min at 37°C or 50 µg PBS per ml at 32°C for 20 min, 0.00036% 4-6 diamidino-2 phenylindole (DAPI)/TBS was applied for 3 min to counterstain nuclei, and Prolong Antifade Kit (Molecular Probes, Eugene, OR) was used as slide mounting media. Serial tissue sections were labeled with PGP 9.5 at 1:1500 dilution for 1 h, biotinylated goat anti-rabbit (Vector Laboratories) at 1:400 dilution for 30 min and fluorescent Cy 5 conjugated streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA) at 1:1000 dilution for 30 min was used. RESULTS PGP 9.5 was detected in nerves and stellate cells in 7, 14, and 21 d wounds PGP 9.5 was observed by ICC to stain cutaneous nerve fibers in the epidermis and dermis of normal skin adjacent to the standard wounds of all ages (Fig 1) . No cellular staining was observed in 1, 2, or 3 d wounds, although staining was occasionally observed in stellate cells adjacent to 4 d wounds. PGP 9.5 was clearly observed in the bed of 7 d wounds in cells with morphologic features of fibroblasts (Fig 2a) . By 14 d, the cellular staining was strong in these stellate cells (Fig 2b) . Similar intensity persisted in the 21 d wounds (not shown). PGP 9.5 staining was observed in most, but not all, of the stellate cells in the granulation tissue of chronic ulcers (Fig 3a) . Stellate cells in the dermis adjacent to the ulcers did not show immunostaining (Fig 3b) .
Ubiquitin was detected in stellate cells in 7, 14, and 21 d wounds Similar to PGP 9.5, ubiquitin staining was observed in stellate cells in the standard human wounds at 7, 14 (Fig 2c, d) , and 21 d (not shown), but not in earlier wounds. Likewise, ubiquitin staining of granulation tissue from chronic decubitus ulcers was also observed (Fig 3c) .
PDGFβ-r was detected in stellate cells in 7, 14, and 21 d wounds Immunostaining for PDGFβ-r was observed in stellate cells of 7, 14 (Fig 2e, f ) , and 21 d old wounds (not shown) but was not observed in earlier wounds. PDGFβ-r staining was noted in endothelial cells and pericytes adjacent to the wounds at all time points studied (not shown).
Confocal microscopy shows PGP 9.5 is expressed by fibroblasts (5B5 positive cells) Confocal microscopy of a 14 d wound (Fig 4) showed further evidence that the stellate cells are fibroblasts. Some stellate cells in the wound bed shown in Fig 4 are stained green by immunofluorescence for PGP 9.5 (Fig 4a) , whereas other stellate cells stained red with the fibroblast marker 5B5 (Fig 4b) . Some cells appear orange on the merged confocal micrograph, indicating costaining for PGP 9.5 and 5B5. It should be noted that not all cells staining with antibodies to 5B5 are positive for PGP 9.5.
Confocal microscopy shows coexpression of PDGFβ-r and PGP 9.5 Figure 5 is a confocal micrograph of the same 14 d wound stained with antibodies to PGP 9.5 (green) and PDGFβ-r (red). Coexpression of the two proteins is demonstrated by costaining of the stellate cells in this merged confocal micrograph.
TEM shows fibroblast ultrastructure for stellate cells Stellate cells in 14 d wounds prepared for TEM include extensive rough endoplasmic reticulum, Golgi membranes, and lack lysosomal vacuoles consistent with fibroblasts (Fig 6) . These cells are closely associated with fibrillar collagen.
RT-PCR of fibroblast RNA shows PGP 9.5 cDNA A 339 bp segment of cDNA was amplified from newborn foreskin fibroblast RNA (Fig 7, lane 1) . Restriction enzyme digestions of the PCR product were consistent with the predicted products corresponding to the PGP 9.5 cDNA sequence 170-508 bp. Gel electrophoresis on the EcoRI-cut PCR product yielded two bands at the expected sizes of 249 and 90 bp (Fig 7, lane 2) , and the MboI-cut PCR product yielded a doublet at the expected sizes of 160 bp and 179 bp (Fig 7, lane 3) . The DNA sequence of the uncut PCR product was identical with the predicted sequence corresponding to the PGP 9.5 cDNA at 170-508 bp (Day and Thompson, 1987) .
Northern blot analysis of fibroblast RNA shows PGP 9.5 mRNA A single band of µ1 kb was visualized with northern blotting of newborn foreskin fibroblast RNA with the 339 bp PGP 9.5 probe. This band corresponds to the predicted intact cDNA of PGP 9.5 (1014 bp) (Day and Thompson, 1987) . . Gel electrophoresis on PGP 9.5 PCR products verifies the appropriate size of DNA fragment. Lane 1 is the uncut PCR product for PGP 9.5 appropriately placed for the 339 bp segment of cDNA predicted. Lane 2 is the Eco RI-cut PCR product for PGP 9.5 showing bands at µ90 and 249 bp as predicted from the known cDNA sequence for PGP 9.5. Lane 3 is the MboI-cut PCR product for PGP 9.5 showing a doublet that corresponds to the predicted 160 and 179 bp restriction products. Lanes M are 100 bp standards.
RT-PCR in situ hybridization shows PGP 9.5 mRNA in wounds stained for PGP 9.5 protein RT-PCR in situ hybridization performed on chronic decubitus ulcers from patients with spinal cord injuries demonstrated marked PGP 9.5 mRNA localization in stellate cells with morphologic features of fibroblasts within the wound bed (Fig 8b) . PGP 9.5 mRNA was not detected in similar cells in the dermis distant from the wound bed (Fig 8c) . It should be noted that not all of the stellate cells in the wound bed exhibited PGP 9.5 mRNA staining, consistent with confocal microscopy that showed similar results for PGP 9.5 protein. PGP 9.5 mRNA was also found in the granular cell layer of the epidermis adjacent to wounds. Additionally, cells surrounding many blood vessels (pericytes) both within and away from the wound bed (Fig 8b, c) were noted to express mRNA for PGP 9.5. TUNEL/PGP 9.5 immunofluorescence shows minimal apoptosis in wounds This experiment was performed to evaluate the role of PGP 9.5 in the apoptosis pathway. As expected for normal epidermis, a few cells in the granular layer of the epidermis adjacent to the 7, 14, and 21 d wounds showed TUNEL positive staining (Fig 9e) . There was only one or two TUNEL positive cells for all time points in the dermal component of the wound bed (Fig 9c, d) , whereas PGP 9.5 staining cells are abundant (Fig 9a, b) . Hence, our findings do not support a role for PGP 9.5 in wound apoptosis during the time periods studied.
DISCUSSION
The staining for PGP 9.5 and ubiquitin appeared in the stellate cells of wounds at day 7 and became more intense in day 14 and 21 wounds. Earlier wounds of 1, 2, and 3 d showed no cellular immunostaining for PGP 9.5. It was also noted that protein staining was limited to the wound area, whereas adjacent skin on the same microscopic section did not show staining. Subsequent studies of tissue from patients with chronic sacral ulcers showed stellate cells staining for both PGP 9.5 and ubiquitin in a pattern similar to the incised wounds.
The stellate cells expressing PGP 9.5 in wounds were identified as fibroblasts, using the following lines of evidence: (i) the stellate cells had morphologic features of fibroblasts by light microscopy and ultrastructural features of fibroblasts by TEM; (ii) confocal microscopy of immunostained sections of wound tissue from a 14 d wound showed colocalization in the stellate cells of PGP 9.5 and 5B5, a relatively specific marker for fibroblasts (Esterre et al, 1992; Bosseloir et al, 1994) ; (iii) we established that newborn foreskin fibroblasts are capable of making mRNA for PGP 9.5, using RT-PCR and northern blot analysis; and (iv) RT-PCR in situ hybridization was used to demonstrate the presence of the mRNA from PGP 9.5 in stellate cells from chronic ulcers.
It is of interest that not all stellate cells in the wound bed appear to express mRNA and protein for PGP 9.5. This suggests that PGP 9.5 is upregulated in fibroblasts in the wound environment and that some, but not all, fibroblasts in wounds express PGP 9.5 at a given time period. A similar observation was made for protein expression of ubiquitin as indicated by ICC in chronic wounds and 7-21 d standard wounds. PGP 9.5 mRNA was expressed in the granular layer, a metabolically active zone of the epidermis as well as in pericytes of blood vessels, in and adjacent to wounds.
Ubiquitin has long been known to play an essential role in cell cycle regulation (Finley and Chau, 1991; Murray, 1995; Ciechanover, 1994) . It has been shown recently in human fibroblasts that the expression of mRNA for p27 (an inhibitor of cyclin-dependent kinases) is constant and that the level of p27 protein is regulated by the level of ubiquitin in cells (Pagano et al, 1995) . A decrease in the level of p27 results in cell division. Therefore, specific proteolysis of p27 may represent one mechanism in wound fibroblasts by which the ubiquitin regulates the activity of cell division. One would expect to see increased ubiquitin expression in the early phases of wound healing with this mechanism because it would be inducing fibroblast proliferation. In this study neither ubiquitin nor PGP 9.5 was detected in the early wounds with the ICC methods, whereas we did observe these proteins in the later phases of repair using ICC.
We observed PDGFβ-r by ICC in stellate cells at 7, 14, and 21 d after wounding. We demonstrated by confocal microscopy coexpression of the PDGFβ-r and PGP 9.5 in stellate cells in 14 and 21 d wounds. We noted staining of PDGFβ-r in endothelial cells and pericytes at earlier time points (1, 2, and 3 d) adjacent to the wounds as previously reported by Reuterdahl et al (1993) . Antoniades et al (1991) reported PDGFβ-r mRNA expression in fibroblasts of partial thickness porcine wounds as well as a PDGF receptor-like protein on ICC by day 1 post-wounding. Antoniades et al (1991) did not examine time points after 9 d. Neither Antoniades et al (1991) nor Reuterdahl et al (1993) used other methods to identify fibroblasts in the wound bed. In our study both TEM and ICC using the 5B5 marker were used to identify fibroblasts in the wound bed.
PDGF is a well-known connective tissue mitogen that also stimulates the production of the connective tissue matrix in wounds (Ross et al, 1986) . Ubiquitinization is important for efficient lysosomal degradation of the PDGFβ-r/ligand complex (Mori et al, 1992) . As a ubiquitin C-terminal hydrolase, PGP 9.5 cleaves ubiquitin from proteins targeted for degradation and allows ubiquitin to be recycled within the cell. The coexpression of PGP 9.5 and PDGFβ-r in more mature wounds suggests that the ubiquitin system may facilitate the degradation of the PDGFβ-r/ligand complex and thus participate in turning off the PDGF mediated fibroblast proliferation and matrix production. Mori et al (1995) have also shown ligand induced ubiquitinization of other tyrosine kinase receptor subfamilies. All the monomeric receptor tyrosine kinases examined were found to be ubiquinated after ligand stimulation, including platelet derived growth factor alpha-receptor, epidermal growth factor receptor, fibroblast growth factor-receptor, and colony stimulation factor-1 receptor (CSF-1R). Like the PDGFβ-r/ligand complex, degradation of each of these complexes could lead to a downregulation of cellular responses in the wound-healing cascade. We are currently investigating whether expression of the PGP 9.5/ubiquitin system is altered in situations of excess connective tissue production after wounding, such as keloids and hypertrophic scars. Others have reported a significant level of apoptosis in maturing granulation tissue of rodents (Desmoulière et al, 1995; Darby et al, 1997; Brown et al, 1997) . In normal rats apoptosis of fibroblasts was most increased in the wound bed at 16-25 d (Desmoulière et al, 1995) . In normal mice the data were directly contradictory regarding apoptosis within the first 14 d (Darby et al, 1997; Brown et al, 1997) . We tried to relate apoptosis to expression of PGP 9.5. We carefully controlled for artifactual DNA degradation or masking of binding sites due to fixation and processing conditions in the TUNEL assay (Lucassen et al, 1995; Strater et al, 1995; Negoescu et al, 1996) . After correction for autofluorescence by use of specific filters with a microscope and deconvolution software, we found very little evidence of apoptosis in 7, 14, and 21 d human wounds. The same wound area on adjacent tissue sections showed widespread ICC staining for PGP 9.5. Hence, our findings do not support a role for the PGP 9.5/ubiquitin system in wound apoptosis during the time periods studied. The absence of apoptosis in 7 and 14 d wounds was consistent with findings in the normal rodent studies. The absence of apoptosis in the 21 d human wounds may reflect a difference in the rate of human and rodent wound maturation or a difference in methods for assessing apoptosis. The DNA fragmentation labeling techniques used for assessing apoptosis are subject to variation based on differences in tissue processing and pretreatment, such as fixative selection, duration of fixation, proteolytic digestion, and microwave irradiation (Lucassen et al, 1995; Strater et al, 1995; Negoescu et al, 1996) .
In summary, PGP 9.5 and ubiquitin were observed in fibroblasts during the granulation tissue and remodeling phases of wound healing. The expression of these degradative proteins in the later phases of wound healing is consistent with a downregulation function for ubiquitin and PGP 9.5 in the wound healing response. Apoptosis did not appear to be a significant mechanism for downregulation of fibroblasts in the human wounds studied.
